Liver Transplantation: How Can We Increase the Number of Donors/Transplants and Create Innovative New Strategies?
The number of liver transplants is small compared to the number of patients in need. How can we increase donors? Are there new techniques to increase the number of live donors, living donors, or use of donations after cardiac death organs? Can we improve the use of marginal donors?
Moderator: Andrew S. Klein, MD, FACS, Manhattan Beach, CA
Co-Moderator: Seth J. Karp, MD, FACS, Nashville, TN
Andrew S. Klein, MD, FACS, Manhattan Beach, CA
Seth J. Karp, MD, FACS, Nashville, TN
Donation after Circulatory Death (DCD) Liver Transplantation: Be Not Afraid of an Underutilized, Life-Saving Resource
David P. Foley, MD, FACS, Madison, WI
Use of Hepatitis C Organs in Liver Transplantation, I Dare You: Use this Organ
Irene K. Kim, MD, FACS, West Hollywood, CA
Steatotic Livers: An Abundant Resource
Kristopher P. Croome, MD, FACS, Jacksonville, FL
Perfusion Devices in Liver Transplantation—Think Inside the Box
Sophoclis P. Alexopoulos, MD, FACS, Nashville, TN
Sponsored by the Advisory Council for General Surgery
- Practicing surgeons
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
For questions about the course, please contact email@example.com.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.
(Download the full list of disclosures).
Faculty and Disclosures
Andrew S. Klein MD, FACS - Nothing to Disclose
David P. Foley MD, FACS - Nothing to Disclose
Irene K. Kim MD, FACS - Nothing to Disclose
Kristopher P. Croome MD, FACS - Nothing to Disclose
Seth J. Karp MD, FACS - Nothing to Disclose
Sophoclis P. Alexopoulos MD, FACS - Nothing to Disclose
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - Nothing to Disclosure
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - Nothing to Disclosure
David C. Borgstrom, MD, FACS, Morgantown, WV - Nothing to Disclosure
Daniel L. Dent, MD, FACS, San Antonio, TX - Nothing to Disclosure
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Cynthia D. Downard, MD, FACS, Louisville, KY - Nothing to Disclosure
Audra A. Duncan, MD, FACS, London, ON - Nothing to Disclosure
Mariam F. Eskander, MD, Boston, MA - Nothing to Disclosure
Paula Ferrada, MD, FACS, Richmond, VA - Nothing to Disclosure
Neil H. Hyman, MD, FACS, Chicago, IL - Nothing to Disclosure
Martin S. Karpeh, Jr., MD, FACS, New York, NY - Nothing to Disclosure
Dennis H. Kraus, MD, FACS, New York, NY - Nothing to Disclosure
Kenneth W. Sharp, MD, FACS, Nashville, TN - Nothing to Disclosure
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - Nothing to Disclosure
Edith Tzeng, MD, FACS, Pittsburgh, PA - Nothing to Disclosure
Barbara Lee Bass, MD, FACS, FRCSEng(Hon), FRCSI(Hon), FCOSECSA(Hon), Houston, TX - Nothing to Disclosure
Quan-Yang Duh, MD, FACS, San Francisco, CA - Nothing to Disclosure
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - Nothing to Disclosure
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - Nothing to Disclosure
Note: Residents will receive a Certificate of Completion.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Certificate of Completion
- 1.50 Self Assessment Credit